NCT05146661 (ARISE-EU) is a NA clinical trial of NEURESCUE device in Cardiac Arrest, sponsored by neurescue.

Who is sponsoring NCT05146661?

NCT05146661 is sponsored by neurescue.

What drugs are being tested in NCT05146661?

Interventions in NCT05146661: NEURESCUE device.

What condition does NCT05146661 study?

NCT05146661 studies Cardiac Arrest, Cardiopulmonary Arrest, Cardiovascular Diseases.

Is NCT05146661 still recruiting?

NCT05146661 is currently completed. Last updated 5 January 2024.

Last reviewed 2024-01-05 · How we verify

NCT05146661: ARISE-EU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

NEURESCUE Device as an Adjunct to Cardiac Arrest

Completed NA Last updated 5 January 2024

What this trial tests

NA trial testing NEURESCUE device in Cardiac Arrest in 10 participants. Completed in 30 November 2023.

Timeline

11 August 2022

Primary endpoint
29 November 2023

30 November 2023

Quick facts

Lead sponsor	neurescue
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	11 August 2022
Primary completion	29 November 2023
Estimated completion	30 November 2023
Sites	2 locations across Germany

Drugs / interventions tested

NEURESCUE device

Conditions studied

Cardiac Arrest — all drugs for Cardiac Arrest →
Cardiopulmonary Arrest — all drugs for Cardiopulmonary Arrest →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

neurescue

Who can join

Adults 18 to 79, any sex, with Cardiac Arrest or Cardiopulmonary Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The NEURESCUE device is the first intelligent balloon catheter for aortic occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending to redirect blood flow towards the upper body. The objective of the study is to investigate the safety and performance of the NEURESCUE device as an adjunct to Advanced Life Support (ALS) in adults with cardiac arrest.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Advanced and Invasive Cardiopulmonary Resuscitation (CPR) Techniques as an Adjunct to Advanced Cardiac Life Support.
Obermaier M, Katzenschlager S, Kofler O, Weilbacher F, et al · · 2022 · cited 10× · PMID 36555932 · DOI 10.3390/jcm11247315

Verify or expand the search:

Other trials of NEURESCUE device

Trials testing the same drug.

NCT05444049 — NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE) · NA · completed

Other recruiting trials for Cardiac Arrest

Currently open trials in the same condition.

NCT07239206 — Serious Game for Improving Targeted Temperature Management Knowledge and Situational Awareness in Critical Care Nurses · NA · recruiting
NCT06780722 — Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Proced · recruiting
NCT06405581 — The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation · recruiting
NCT06511999 — Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest · recruiting
NCT07113769 — Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation · recruiting

Other neurescue trials

Trials by the same sponsor.

NCT05444049 — NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE) · NA · completed
NCT04491903 — REBOA for Out-of-hospital Cardiac Arrest · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05146661 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by neurescue
Last refreshed: 5 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05146661.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing